PDS Biotechnology Corporation’s recent filing unveils that its Director Freitag Gregory Gene acquired Company’s shares for reported $25000.0 on Feb
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
PDS Biotechnology Corporation’s recent filing unveils that its Director Freitag Gregory Gene acquired Company’s shares for reported $25000.0 on Feb
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
PDS Biotechnology Corporation’s recently made public that its Director Freitag Gregory Gene acquired Company’s shares for reported $25000.0 on Feb
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
PDS Biotechnology Corporation’s filing revealed that its Director Freitag Gregory Gene acquired Company’s shares for reported $25000.0 on Feb 28
PDS Biotechnology Corporation (NASDAQ:PDSB) does about 682.76K shares in volume on a normal day but saw 403595 shares change hands